Search

everythinglearnresearchcommunity

for

Search:↓

Azathioprine caused side effects in over half of the Korean pediatric inflammatory bowel disease patients, requiring close monitoring.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

Infliximab can cause SAPHO syndrome, which may improve with Spesolimab and methotrexate.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.

Hair loss in a child was an early sign of Crohn's disease.

Patients with autoimmune blistering diseases experience a reduced quality of life, with the need for better measurement tools, especially for those with mucous membrane pemphigoid.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.

Iressa often causes skin issues like acne and dryness in lung cancer patients.

Recognizing IPPP is crucial to prevent misdiagnosis and unnecessary treatments.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and inhaled budesonide.

Tip cryotherapy effectively treats idiopathic guttate hypomelanosis with minimal side effects.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

IND-Ca ointment effectively reduces inflammation with minimal skin irritation.

The document concludes that various skin conditions have specific characteristics and treatments, and highlights the importance of vitamin D in managing these dermatological issues.

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Ixekizumab has known and some unexpected side effects.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

A 78-year-old farmer with lung disease had skin lesions from a fungal infection that healed completely with medication.

Thermal imaging is a useful non-invasive method to diagnose active inflammation in frontal fibrosing alopecia.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Early detection, prevention, and proper management can reduce TB-IRIS complications and deaths in HIV patients.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.